NVDA
NVIDIA
-- 139.889 TSLA
Tesla
-- 351.150 INTC
Intel
-- 26.095 GRAB
Grab Holdings
-- 5.274 SMCI
Super Micro Computer
-- 53.370 
NEWS
Intelligent Bio Solutions Achieves 94.1% Accuracy in Method Comparison Study, Following Positive PK Study Results
Intelligent Bio Solutions (INBS) has successfully completed its method comparison study for the Intelligent Fingerprinting Drug Screening System, achieving 94.1% accuracy, 82.2% sensitivity, and 100% specificity.
The study, conducted with CenExel using 135 healthy donors and nine system operators, compared fingerprint sweat opiate screening tests with laboratory LC-MS/MS methods.
This milestone, along with recent positive Pharmacokinetic study results, supports INBS's planned FDA 510(k) submission in Q4 2024. If approved, the company aims to launch its non-invasive drug screening technology in the US market in 2025
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
8224
Followers
52
Following
94K
Visitors
Follow
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
Lnova : I have to read up on this. I’m wondering if it can screen for drugs using fingerprints?![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
crazy
Lnova : Intelligent Bio Solutions Inc. Moves Forward With FDA 510(k) Submission for Intelligent Fingerprinting Drug Screening System woww very valuable thing. Fingerprinting much more convenient than other methods of testing.
Lnova : I’m surprised this stock doesn’t have more volume… fingerprint testing that’s a big deal…